Evidence map›Paper›PMID 36605832›Full record

ArticleInternational cancer conference journal2023

Rapid-onset paraneoplastic cerebellar degeneration successfully treated by radiotherapy and tumorectomy.

Philippe Westerlinck, Nicolas Janin, Philippe Coucke

Open access · greenAbstract readCase Reports
In one paragraph

Article in International cancer conference journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Philippe WesterlinckDepartment of Radiation Oncology, Centre hospitalier universitaire de Liège, Avenue de L'Hôpital 1, 4000 Liège, Belgium.ORCID 0000-0002-1463-7884
Nicolas JaninDepartment of Medical Oncology, Centre Hospitalier Régional de la Citadelle, Liège, Belgium.
Philippe CouckeDepartment of Radiation Oncology, Centre hospitalier universitaire de Liège, Avenue de L'Hôpital 1, 4000 Liège, Belgium.
Centre Hospitalier Universitaire de Liège · BECentre hospitalier régional de la Citadelle · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the first-ever documented case of successful treatment of paraneoplastic cerebellar degeneration (PCD) with radiotherapy. A 31-year-old female presented with rapidly progressing neurological symptoms, which were revealed to be due to PCD secondary to an undiagnosed breast cancer. The cancer responded well to chemotherapy, but her neurological status continued to deteriorate, eventually progressing to complete expressive aphasia and dyssynergia with paraparesis. Due to the extraordinarily rapid progression of the disorder, a treatment with tumorectomy and radiotherapy of the whole brain was performed. This proved to be very successful, with a complete stop of the deterioration of symptoms after treatment and with a significant neurologic improvement in the following months. This case indicates that there may be a place for radiotherapy in the treatment of PCD. Current treatment options have proven insufficient and no guidelines for treatment currently exist. As such, the disorder remains associated with a very poor prognosis and often entails permanent loss of function. Radiation, with its known immunosuppressive effect and non-stochastic effects on the nervous system at the proper doses, might therefore be a valid option. However, we should note that it was in this instance combined with a removal of the primary tumor and as such, its individual efficacy cannot be considered proven.

Indexed as

Anti-Yo antibodyAtaxiaParaneoplastic cerebellar degenerationRadiotherapy

Identifiers

PMID36605832
PMCPMC9807696
OpenAlexW4289845773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.